Financialsexperimental
GOLDMAN SACHS GROUP INC (GSCE). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in millions
| Balance Sheet | FY FY25 31 Dec 2025 | FY FY24 31 Dec 2024 | FY FY23 31 Dec 2023 | FY FY22 31 Dec 2022 | FY FY21 31 Dec 2021 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 164,259 | 182,092 | 241,577 | 241,825 | 261,036 |
| Securities purchased under agreements to resell (includes $121,206 and $126,007 at fair value) | 126,007 | 180,062 | 223,805 | 225,117 | 205,703 |
| Securities borrowed (includes $61,756 and $51,581 at fair value) | 208,208 | 194,645 | 199,420 | 189,041 | 178,771 |
| Customer and other receivables (includes $23 and $25 at fair value) | 135,448 | 160,673 | |||
| Customer and other receivables (includes $292 and $315 at fair value) | 185,842 | 133,717 | 132,495 | ||
| Trading assets (at fair value and includes $97,406 and $40,143 pledged as collateral) | 301,245 | 375,916 | |||
| Trading assets (at fair value and includes $185,318 and $158,641 pledged as collateral) | 656,796 | 570,555 | 477,510 | ||
| Investments (includes $103,509 and $75,767 at fair value) | 146,839 | 130,629 | 88,719 | ||
| Loans (net of allowance of $4,562 and $3,573, and includes $9,492 and $10,769 at fair value) | 158,562 | ||||
| Available-for-sale securities (at fair value; amortized cost of $156,636 and $99,116) | 99,244 | 79,458 | |||
| Held-to-maturity securities | 69,193 | 78,713 | |||
| Other investments (includes $24,343 and $24,938 at fair value) | 25,825 | 26,343 | |||
| Loans (net of allowance of $2,188 and $2,148, and includes $4,640 and $4,905 at fair value) | 237,734 | 196,200 | 183,358 | 179,286 | |
| Other assets (includes $202 and $180 at fair value) | 36,212 | 34,187 | 36,590 | 39,208 | 34,608 |
| Total assets | 1,809,320 | 1,675,972 | 1,641,594 | 1,441,799 | 1,463,988 |
| Deposits (includes $90,249 and $76,569 at fair value) | 501,422 | 433,013 | 428,417 | 386,665 | 364,227 |
| Securities sold under agreements to repurchase (at fair value) | 223,384 | 274,380 | 249,887 | 110,349 | 165,883 |
| Securities loaned (includes $12,871 and $11,995 at fair value) | 53,644 | 56,060 | 60,483 | 30,727 | 46,505 |
| Other secured financings (includes $34,865 and $27,833 at fair value) | 28,021 | 28,150 | 13,194 | 13,946 | 18,544 |
| Customer and other payables | 231,865 | 223,255 | 230,728 | 262,045 | 251,931 |
| Trading liabilities (at fair value) | 262,552 | 202,555 | 200,355 | 191,324 | 181,424 |
| Unsecured short-term borrowings | 70,459 | 69,709 | 75,945 | 60,961 | 46,955 |
| Unsecured long-term borrowings (includes $144,703 and $112,683 at fair value) | 285,500 | 242,634 | 241,877 | 247,138 | 254,092 |
| Other liabilities (includes $264 and $111 at fair value) | 27,501 | 24,220 | 23,803 | 21,455 | 24,501 |
| Total liabilities | 1,684,348 | 1,553,976 | 1,524,689 | 1,324,610 | 1,354,062 |
| Preferred stock; aggregate liquidation preference of $13,028 and $15,153 | 15,153 | 13,253 | 11,203 | 10,703 | 10,703 |
| Common stock; 936,341,620 and 931,995,446 shares issued, and 291,442,355 and 296,476,742 shares outstanding | 9 | 9 | 9 | 9 | 9 |
| Share-based awards | 5,795 | 5,148 | 5,121 | 5,696 | 4,211 |
| Nonvoting common stock; no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 |
| Additional paid-in capital | 61,906 | 61,376 | 60,247 | 59,050 | 56,396 |
| Retained earnings | 165,288 | 153,412 | 143,688 | 139,372 | 131,811 |
| Accumulated other comprehensive loss | -2,260 | -2,702 | -2,918 | -3,010 | -2,068 |
| Stock held in treasury, at cost; 644,899,267 and 635,518,706 shares | -120,919 | -108,500 | -100,445 | -94,631 | -91,136 |
| Total shareholders’ equity | 124,972 | 121,996 | 116,905 | 117,189 | 109,926 |
| Total liabilities and shareholders’ equity | 1,809,320 | 1,675,972 | 1,641,594 | 1,441,799 | 1,463,988 |